XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities:    
Net loss $ (2,365,241) $ (2,438,355)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,850
Non-cash operating lease expense 35,325 33,613
Depreciation 6,691 6,691
Changes in operating assets and liabilities    
Short term receivables 465 (553)
Prepaid expenses and other current assets 267,991 359,572
Accounts payable (294,892) (308,728)
Unearned grant revenue (602,808) (436,600)
Other accrued expenses 449,721 653,664
Operating lease liability (35,662) (32,938)
Accrued interest 166,327 150,017
Net Cash Used In Operating Activities (2,372,083) (2,010,767)
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes payable 353,000 700,000
Proceeds from issuance of convertible notes payable - related parties 1,950,000 1,525,000
Repayment of short-term note payable (243,554) (234,997)
Repayment of 2021 convertible note payable - related party (100,000)
Net Cash Provided By Financing Activities 1,959,446 1,990,003
Effect of exchange rates on cash and restricted cash 27 (736)
Net Decrease In Cash and Restricted Cash (412,610) (21,500)
Cash and Restricted Cash, Beginning of Period 1,026,799 1,431,707
Cash and Restricted Cash, End of Period 614,189 1,410,207
Cash 187,457 367,250
Restricted cash 426,732 1,042,957
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Conversion of 2021 Notes and related accrued interest to Series D-1 Preferred Stock 804,533
Conversion of 2022 Notes and related accrued interest to Series D-1 Preferred Stock 2,404,057 170,126
Conversion of accrued directors’ fees to Series D-1 Preferred Stock 2,131,839
Forfeited shares of Series D Preferred Stock (11,416)
Issuance of Series D-1 Preferred Stock for forfeited shares of Series D Preferred Stock 1,141
Purchase of insurance policies financed by short-term note payable $ (76,283) $ (73,669)